CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (90,445)	$ (80,298)	$ (34,567)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	55,836	34,745	26,584
Impairment charges		5,686
Equity-based compensation	14,552	11,608	8,708
Provision for credit losses	1,890	2,316	979
Amortization of deferred financing fees included in interest expense	4,638	3,224	3,517
Write-off of unamortized deferred financing fees	137
(Gain) loss on disposal of property, plant and equipment	1,278	(1,722)	1,153
Gain on de-consolidation of Rwanda Trading Company	(2,291)
Mark-to-market adjustments	629	(4,622)	(104)
Change in fair value of warrant liabilities	0	(7,015)	(10,207)
Foreign currency transactions	(141)	598	1,864
Deferred income tax expense (benefit)	(3,088)	3,287	(6,512)
Other	(3,347)	1,257	2,486
Change in operating assets and liabilities:
Accounts receivable	(6,960)	(2,766)	1,688
Inventories	(46,903)	(6,558)	915
Derivative assets and liabilities	(6,010)	16,383	6,440
Prepaid expense and other assets	3,349	1,983	(1,890)
Accounts payable	34,454	5,693	(59,292)
Accrued liabilities and other	23,408	2,958	(5,826)
Net cash used in operating activities	(19,014)	(13,243)	(64,064)
Cash flows from investing activities:
Additions to property, plant and equipment	(88,800)	(159,625)	(164,611)
Additions to intangible assets	(174)	(173)	(173)
Acquisition of business, net of cash acquired			(2,392)
Proceeds from sale of equity method investments and non-marketable securities	500
Acquisition of equity method investments and non-marketable securities, inclusive of cash contributed	(2,952)		(1,385)
Proceeds from sale of property, plant and equipment	462	13,875	206
Proceeds from deferred purchase price of sold trade receivables	8,788
Net cash used in investing activities	(82,176)	(145,923)	(168,355)
Cash flows from financing activities:
Payments on debt	(126,487)	(181,242)	(199,196)
Proceeds from debt	185,853	278,141	258,490
Payments on supply chain financing program	(181,513)	(163,869)	(32,141)
Proceeds from supply chain financing program	199,269	164,631	110,217
Proceeds from convertible notes payable	18,500	22,000
Proceeds from convertible notes payable - related party	11,500	50,000
Payment of debt issuance costs	(4,016)	(3,329)	(3,158)
Payment of convertible notes payable issuance costs	(1,175)	(511)
Net proceeds from (repayments of) repurchase agreements	11,209	(7,706)	(6,268)
Net change in unremitted cash collections from servicing factored receivables	13,756
Proceeds from exercise of stock options		12	848
Proceeds from exercise of Public Warrants			2,632
Proceeds from issuance of common stock	12,097	635	118,767
Payment of equity issuance costs	(181)	(10)	(1,000)
Payment for purchase of non-controlling interest			(2,000)
Payment for taxes for net share settlement of equity awards	(2,098)	(2,122)	(2,977)
Net cash provided by financing activities	136,714	156,630	244,214
Effect of exchange rate changes on cash	(49)	260	(360)
Net increase (decrease) in cash and cash equivalents and restricted cash	35,475	(2,276)	11,435
Cash and cash equivalents and restricted cash at beginning of period	35,564	37,840	26,405
Cash and cash equivalents and restricted cash at end of period	71,039	35,564	37,840
Supplemental non-cash investing and financing activities:
Property, plant and equipment acquired but not yet paid	12,889	32,582	23,124
Amounts obtained as beneficial interest in sold trade receivables	10,630
Supplemental cash flow information:
Cash paid for interest	$ 49,398	$ 37,552	$ 29,446